WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 413438

CAS#: 79553-45-0

Description: Cytovaricin is a novel antibiotic from Streptomyces sp. No. H-230.

Chemical Structure

CAS# 79553-45-0

Theoretical Analysis

MedKoo Cat#: 413438
Name: Cytovaricin
CAS#: 79553-45-0
Chemical Formula: C47H80O16
Exact Mass: 900.5446
Molecular Weight: 901.14
Elemental Analysis: C, 62.64; H, 8.95; O, 28.41

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Cytovaricin; BRN4226438; BRN-4226438; BRN 4226438

IUPAC/Chemical Name: COMPOUND SUMMARY CID 6436235 PubChem CID 6436235 Structure CID 6436235_small.png Find Similar Structures Molecular Formula C47H80O16 Synonyms Cytovaricin NSC 349622 BRN 4226438 H-230 79553-45-0 More... Molecular Weight 901.1 g/mol Dates Modify 2021-02-27 Create 2006-04-28 1Structures HelpNew Window 1.12D Structure HelpNew Window Find Similar Structures Get Image Download Chemical Structure Depiction CID 6436235.png Full screen Zoom in Zoom out PubChem 1.23D Status HelpNew Window Conformer generation is disallowed since too many atoms PubChem 2Names and Identifiers HelpNew Window 2.1Computed Descriptors HelpNew Window 2.1.1IUPAC Name HelpNew Window (1S,3S,5'S,6S,6'S,8S,9E,14R,15R,16S,17R,18S,19S,20R,21E,25S,27R,29R)-3,14,15,17,19,20-hexahydroxy-6'-[(2R)-2-hydroxybutyl]-16-[(2S,4S,5R,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5',6,14,18,20,29-hexamethylspiro[4,24,28-trioxatricyclo[,8]nonacosa-9,21-diene-27,2'-oxane]-23-one


InChi Code: InChI=1S/C47H80O16/c1-10-32(48)21-33-27(3)15-19-46(62-33)23-35-28(4)36(63-46)24-47(56)31(20-26(2)25-58-47)14-12-11-13-17-44(7,54)43(53)41(61-38-22-34(57-9)40(51)30(6)59-38)39(50)29(5)42(52)45(8,55)18-16-37(49)60-35/h12,14,16,18,26-36,38-43,48,50-56H,10-11,13,15,17,19-25H2,1-9H3/b14-12+,18-16+/t26-,27-,28-,29-,30+,31+,32+,33-,34-,35-,36-,38-,39+,40+,41-,42-,43+,44+,45+,46+,47-/m0/s1

SMILES Code: CC[C@H](C[C@@H]1O[C@]2(C[C@@H]3OC(/C=C/[C@@](O)([C@H]([C@H]([C@H]([C@@H]([C@H]([C@](O)(CCC/C=C/[C@@H]4C[C@@H](CO[C@]4(C[C@@H]([C@H]3C)O2)O)C)C)O)O[C@H]5C[C@@H]([C@@H]([C@H](O5)C)O)OC)O)C)O)C)=O)CC[C@@H]1C)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 901.14 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Yamashita N, Kazuo SY, Kitamura M, Wakao H, Furihata K, Furihata K, Hayakawa Y, Miyajima A, Seto H. Cytovaricin B, a new inhibitor of JAK-STAT signal transduction produced by Streptomyces torulosus. J Antibiot (Tokyo). 1997 May;50(5):440-2. doi: 10.7164/antibiotics.50.440. PMID: 9207915.

2: Kihara T, Kusakabe H, Nakamura G, Sakurai T, Isono K. Cytovaricin, a novel antibiotic. J Antibiot (Tokyo). 1981 Aug;34(8):1073-4. doi: 10.7164/antibiotics.34.1073. PMID: 7319923.

3: Kihara T, Ubukata M, Uzawa J, Isono K. Biosynthesis and 13C NMR assignment of cytovaricin, a neutral macrolide antibiotic. J Antibiot (Tokyo). 1989 Jun;42(6):919-25. doi: 10.7164/antibiotics.42.919. PMID: 2737951.

4: Kihara T, Isono K. The absolute configuration of cytovaricin: isolation of methyl beta-D-cymaroside by methanolysis. J Antibiot (Tokyo). 1983 Sep;36(9):1236. doi: 10.7164/antibiotics.36.1236. PMID: 6630081.

5: Trost BM, O'Boyle BM, Hund D. Total synthesis and stereochemical assignment of (-)-ushikulide A. J Am Chem Soc. 2009 Oct 21;131(41):15061-74. doi: 10.1021/ja906056v. PMID: 19775093; PMCID: PMC2791109.

6: Salomon AR, Voehringer DW, Herzenberg LA, Khosla C. Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase. Chem Biol. 2001 Jan;8(1):71-80. doi: 10.1016/s1074-5521(00)00057-0. PMID: 11182320.

7: Salomon AR, Zhang Y, Seto H, Khosla C. Structure-activity relationships within a family of selectively cytotoxic macrolide natural products. Org Lett. 2001 Jan 11;3(1):57-9. doi: 10.1021/ol006767d. PMID: 11429871.

8: Kirst HA, Mynderse JS, Martin JW, Baker PJ, Paschal JW, Rios Steiner JL, Lobkovsky E, Clardy J. Structure of the spiroketal-macrolide ossamycin. J Antibiot (Tokyo). 1996 Feb;49(2):162-7. doi: 10.7164/antibiotics.49.162. PMID: 8621357.

9: Kirst HA, Larsen SH, Paschal JW, Occolowitz JL, Creemer LC, Steiner JL, Lobkovsky E, Clardy J. Structure of the new spiroketal-macrolide A82548A. J Antibiot (Tokyo). 1995 Sep;48(9):990-6. doi: 10.7164/antibiotics.48.990. PMID: 7592067.

10: Salomon AR, Voehringer DW, Herzenberg LA, Khosla C. Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase. Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14766-71. doi: 10.1073/pnas.97.26.14766. PMID: 11121076; PMCID: PMC18993.